Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "drug"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint false, but the description goes well beyond them. It discloses that every identifier is source-labelled, unresolved identifiers are listed explicitly under 'unresolved', ambiguous matches yield 'figi_candidates', and the tool cascades through multiple internal endpoints (replacing 2-3 lookups). This gives the agent a clear mental model of what happens and what to expect in ambiguous or degraded cases.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and densely packed, but essentially every sentence contributes new information—usage triggers, supported types, behavioral nuances, and degradation handling. It front-loads example queries and the primary use case, and uses parentheses for secondary details. Though not a model of brevity, it does not contain tautologies or filler; the length is justified by the tool's complexity and the absence of an output schema.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema, the description provides a thorough account of what is returned: identifiers with source labels, an explicit 'unresolved' field for failures, and 'figi_candidates' for ambiguous matches. It also documents both supported types fully and explains the input formats for each. An agent given a name and needing an ID has enough information to invoke this tool correctly and interpret its result.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema already describes both parameters, but the description adds significant meaning. For 'value', it explains accepted formats per type (ticker, CIK, ISIN, name for company; brand or generic for drug), and explicitly instructs to pass only the entity name, even offering a negative example for bonds. This level of detail prevents common invocation errors and goes far beyond the schema's one-line descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states the specific verb 'resolve' with the resource 'entity', and explains it maps user-spoken names to canonical identifiers (CIK, ticker, LEI, FIGI, RxCUI). It also distinguishes itself from likely siblings by framing it as the first lookup step ('Use FIRST whenever you have a name but need an ID'), and clarifies that it handles non-equity securities that other tools may miss. The purpose is unambiguous and not a tautology.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states when to use the tool ('Use FIRST whenever you have a name but need an ID') and provides example queries. It also gives negative guidance: for ambiguous name matches it returns candidates rather than guessing, and it warns against including trailing security-class words in bond issuer names. It even notes graceful degradation when enrichment sources are unavailable. This is comprehensive usage guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.4/5.0
Disambiguation2/5

Multiple tools have overlapping purposes: ask_pipeworx and ask_pipeworx_beta are functionally identical (beta just has experimental routing), and the Polymarket suite (bet_research, polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread) all revolve around prediction-market signal detection with unclear boundaries. Also ai_visibility_check and scan_competitor_ai_presence overlap heavily.

Naming Consistency2/5

Naming is a mix of verb-first (draw_cards, resolve_entity, discover_tools) and noun-first (entity_profile, new_deck, recent_alerts) styles, with inconsistent prefixes (pipeworx_feedback vs ask_pipeworx) and no unifying convention. Some tools are bare verbs (recall, remember), others are noun phrases (polymarket_edges).

Tool Count2/5

34 tools is excessive for a server named 'deckofcards' — only 3 tools relate to cards. Even as a general-purpose data/research server, 34 is on the high end and includes many near-duplicates (ask_pipeworx variants) and highly specialized tools that could be consolidated.

Completeness3/5

The research side is fairly complete (lookup, grounding, comparison, profiles, claim verification, memory, subscriptions), but the card-deck functionality is minimal (only create, draw, shuffle) and lacks any deck inspection or hand management. The server's scope is unclear, making it hard to assess true coverage.